It's not often you come across a true value stock in the pharmaceutical sector. There are more than a few stocks in the sector that come up on a variety of standard value screens -- price-to-cash, price-to-book, NCAV -- but those are generally biotech or early-stage development companies which are burning through significant amounts of their seemingly impressive asset bases.
It's what makes Cumberland Pharmaceuticals (NASDAQ:CPIX) so surprising. The stock closed Friday at $4.44 per share, giving it a market capitalization of just under $85 million. Yet the company has some $65 million in cash and securities on its balance sheet, net of its exposure to a small line of credit, putting its enterprise value below $20 million....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|